The University of Arizona is among 18 institutions participating in a $28 million, five-year Martin Delaney Collaboratory grant awarded today to George Washington University by the National Institutes of Health (NIH) to marshal various immunotherapy advances to create a novel HIV cure strategy.
The University of Arizona Health Sciences and Banner Health have been awarded a $4 million grant from the National Institutes of Health to participate in the Precision Medicine Initiative® Cohort Program, which aims to enroll 1 million or more U.S. participants to improve prevention and treatment of disease based on individual differences in lifestyle, environment and genetics.
The day after his son’s twins were born in 2012, Gary Brauchla, 68, went into cardiac arrest as he slept in his home in Pearce, Ariz.
Nearly a hundred people participated in the regional summit hosted June 29 by the University of Arizona Cancer Center as part of the nationwide Cancer Moonshot events sponsored by the White House as part of an initiative to marshal resources to cure cancer.
The University of Arizona Division of Cardiology and UA Sarver Heart Center announced their full list of incoming as well as graduating fellows from their two fellowship programs.
Banner Health’s new website was unveiled today at 10:45 a.m.
“Top Doctors” affiliated with the University of Arizona Department of Medicine who got special full-page features—as well as listings—in the July issue of Tucson Lifestyle magazine include Cardiology’s Raj Janardhanan, MD, and Hematology & Oncology’s
The Petersen HIV Clinics pharmacy team will provide a brief presentation and Q&A on Friday, July 22, about new and future treatments for human immunodeficiency virus (HIV) and AIDS at the Leon Levy Cancer Center building, located in front of the Banner – University Medical Center Tucson hospital.
“Clinical Trials” is the theme of the next Open House at the UA Cancer Center – North Campus, 3838 N. Campbell Ave., on Thursday, July 28, 5-7 p.m.
Daruka Mahadevan, MD, PhD, new director of the UA Cancer Center’s Phase I Clinical Trials Program and Experimental Therapeutics co-director, and his team will present on options and opportunities in our clinical trials program.
Biomedical engineer Jennifer Barton is renowned for her development of biomedical imaging technologies. (Photo courtesy of BIO5 Institute)
University of Arizona researcher Jennifer Barton, PhD, is leading a two-year, $1 million project funded by the National Cancer Institute to identify imaging biomarkers of ovarian cancer, the most deadly gynecological cancer in the United States.
